연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
915. Soluble mediators from human neural stem cells play a critical role in suppression of T-cell activation and proliferation.
Kim SY, Cho HS, Yang SH, Shin JY, Kim JS, Lee ST, Chu K, Roh JK, Kim SU, Park CG.
J Neurosci Res. 2009 Aug 1;87(10):2264-72.
Link
914. Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10.
Yang SH, Park MJ, Yoon IH, Kim SY, Hong SH, Shin JY, Nam HY, Kim YH, Kim B, Park CG.
Exp Mol Med. 2009 May 31;41(5):315-24.
Link
913. High-dose cyclophosphamide-mediated anti-tumor effects by the superior expansion of CD44(high) cells after their selective depletion.
Hong SH, Yoon IH, Kim YH, Yang SH, Park MJ, Nam HY, Kim B, Kim Y, Park CS, Park CG.
Immunobiology. 2009 May 21. [Epub ahead of print]
Link
912. omib can suppress activation of rapamycin-resistant memory T cells without affecting regulatory T-cell viability in non-human primates.
Kim JS, Lee JI, Shin JY, Kim SY, Shin JS, Lim JH, Cho HS, Yoon IH, Kim KH, Kim SJ, Park CG.
Transplantation. 2009 Dec 27;88(12):1349-59.
Link
911. Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cells.
Kim TY, Kim IS, Jong HS, Lee JW, Kim TY, Jung M, Bang YJ.
Exp Mol Med. 2008 Dec 31;40(6):639-46.
Link
910. Correlation between plasma activity of ADAMTS-13 and coagulopathy, and prognosis in disseminated intravascular coagulation.
Hyun J, Kim HK, Kim JE, Lim MG, Jung JS, Park S, Cho HI.
Thromb Res. 2009 May;124(1):75-9. Epub 2009 Jan 21.
Link
909. Prognostic value of immature platelet fraction and plasma thrombopoietin in disseminated intravascular coagulation.
Hong KH, Kim HK, Kim JE, Jung JS, Han KS, Cho HI.
Blood Coagul Fibrinolysis. 2009 Sep;20(6):409-14.
Link
908. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
Seo JW, Kim HK, Kim JE, Park S, Cho HI.
Thromb Res. 2009 Feb;123(4):565-72. Epub 2008 May 13.
Link
907. Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival.
Kim JS, Kim MA, Kim TM, Lee SH, Kim DW, Im SA, Kim TY, Kim WH, Yang HK, Heo DS, Bang YJ, Lee KU, Choe KJ, Kim NK.
Br J Cancer. 2009 Mar 10;100(5):732-8.
Link
906. Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells.
Yoon YK, Kim HP, Han SW, Hur HS, Oh do Y, Im SA, Bang YJ, Kim TY.
Mol Cancer Ther. 2009 Sep;8(9):2526-36. Epub 2009 Sep 15.
Link